Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

NCT01761526 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rotigotine transdermal patch

Sponsor

UCB BIOSCIENCES GmbH

Collaborators

[object Object]
[object Object]
[object Object]